Capitalist Palliatives: Antidepressants, and How Not to Talk About Them

Vivek Santayana | March 30, 2018
A few weeks ago, the philosopher and literary critic Timothy Morton took a dig at his late colleague Mark Fisher, who committed suicide last year after a lifelong struggle with depression. Morton claimed the one big difference between himself and Fisher was that he took antidepressants, and so is still alive to write his new book. He was commenting on Fisher’s critique of neoliberal ideologies that shape discourses around mental health and pharmacological treatment. Morton’s tweet read like an insensitive gloat at his outliving his colleague whose opinion he disagrees with. At best, it was an ad hominem attack dismissing Fisher through a crude, mischaracterised version of his argument.

Read Article →

Antidepressants after Prozac Nation

Maria Elena Torres-Quevedo | 10th July 2017.

Twenty-three years after the publication of American author Elizabeth Wurtzel’s memoir entitled Prozac Nation: Young and Depressed in America (1994), public opinion about antidepressants is still as rife with misconceptions, fear, and judgement, as it was when Wurtzel was first prescribed medication to manage her persistent and devastating depression. Writing in what is now a significant traditional of women’s narratives of mental illness— including Sylvia Plath’s The Bell Jar (1963), Susanna Kaysen’s Girl, Interrupted (1999), and Marya Hornbacher’s Madness (2008)—  Wurtzel details the brutal development of her depression from early adolescence into adulthood, and notes the rise in illnesses such as hers across the country.

Read Article →